Aequus Pharmaceuticals Inc.

Aequus Pharmaceuticals Inc.verified

AQSZF

Price:

$0.015

Market Cap:

$2.70M

Aequus Pharmaceuticals Inc., a specialty pharmaceutical company, develops and commercializes drugs in Canada. It focuses on various therapeutic areas, including neurology, ophthalmology, and transplantation. The company markets Vistitan, an ophthalmology product to reduce elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Tacrolimus IR, an immunosuppressant for the treatment and prevention of acute rejection following organ transplantation; Evolve dry eye products for various symptoms involved with dry eye disease and blepharitis, including discomfort, stinging, burning, and dryness; and preservative free ophthalmic product. Its development stage produ...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2015-06-16

Stock Exchange

PNK

Ticker

AQSZF

The PE Ratio as of September 2024 (TTM) for Aequus Pharmaceuticals Inc. (AQSZF) is -1.50

According to Aequus Pharmaceuticals Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -1.50. This represents a change of 27.64% compared to the average of -1.18 of the last 4 quarters.

Aequus Pharmaceuticals Inc. (AQSZF) Historical PE Ratio (quarterly & annually)

How has AQSZF PE Ratio performed in the past?

The mean historical PE Ratio of Aequus Pharmaceuticals Inc. over the last ten years is -4.54. The current -1.50 PE Ratio has changed 3.21% with respect to the historical average. Over the past ten years (40 quarters), AQSZF's PE Ratio was at its highest in in the March 2024 quarter at -0.86. The PE Ratio was at its lowest in in the December 2020 quarter at -18.69.

Quarterly (TTM)
Annual

Average

-4.54

Median

-4.16

Minimum

-9.82

Maximum

-1.27

Aequus Pharmaceuticals Inc. (AQSZF) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Aequus Pharmaceuticals Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 213.67%

Maximum Annual PE Ratio = -1.27

Minimum Annual Increase = -83.84%

Minimum Annual PE Ratio = -9.82

Quarterly (TTM)
Annual
YearPE RatioChange
2023-1.27-3.28%
2022-1.31-83.84%
2021-8.10-17.54%
2020-9.82213.67%
2019-3.13-24.72%
2018-4.16-32.07%
2017-6.12162.66%
2016-2.33-44.05%
2015-4.17-15.82%
2014-4.95-13.50%

Aequus Pharmaceuticals Inc. (AQSZF) Average PE Ratio

How has AQSZF PE Ratio performed in the past?

The current PE Ratio of Aequus Pharmaceuticals Inc. (AQSZF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-3.56

5-year avg

-4.73

10-year avg

-4.54

Aequus Pharmaceuticals Inc. (AQSZF) PE Ratio vs. Peers

How is AQSZF’s PE Ratio compared to its peers?

Aequus Pharmaceuticals Inc.’s PE Ratio is less than Amexdrug Corporation (216.50), greater than Aion Therapeutic Inc. (-1.81), less than Aspen Pharmacare Holdings Limited (363.87), greater than Antisense Therapeutics Limited (-3.24), greater than Alterola Biotech, Inc. (-11.85), less than The BC Bud Corporation (-0.63), less than Crescita Therapeutics Inc. (-0.19), less than AusCann Group Holdings Ltd (-0.26),

Build a custom stock screener for Aequus Pharmaceuticals Inc. (AQSZF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Aequus Pharmaceuticals Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Aequus Pharmaceuticals Inc. (AQSZF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Aequus Pharmaceuticals Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Aequus Pharmaceuticals Inc.'s PE Ratio?

How is the PE Ratio calculated for Aequus Pharmaceuticals Inc. (AQSZF)?

What is the highest PE Ratio for Aequus Pharmaceuticals Inc. (AQSZF)?

What is the 3-year average PE Ratio for Aequus Pharmaceuticals Inc. (AQSZF)?

What is the 5-year average PE Ratio for Aequus Pharmaceuticals Inc. (AQSZF)?

How does the current PE Ratio for Aequus Pharmaceuticals Inc. (AQSZF) compare to its historical average?